Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells

被引：0
|
作者：
Tomonori Tanei
Dong Soon Choi
Angel A. Rodriguez
Diana Hwang Liang
Lacey Dobrolecki
Madhumita Ghosh
Melissa D. Landis
Jenny C. Chang
机构：
[1] Methodist Cancer Center,Department of Surgery
[2] Houston Methodist Hospital,undefined
[3] Houston Methodist Hospital,undefined
来源：
Breast Cancer Research | / 18卷
关键词：
Epidermal Growth Factor Receptor; Cetuximab; Triple Negative Breast Cancer; Epidermal Growth Factor Receptor Signaling; Ixabepilone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
    Tanei, Tomonori
    Choi, Dong Soon
    Rodriguez, Angel A.
    Liang, Diana Hwang
    Dobrolecki, Lacey
    Ghosh, Madhumita
    Landis, Melissa D.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2016, 18
  • [2] Antitumor Activity and Cancer Stem Cells Effect of Cetuximab in Combination with Ixabepilone in Triple Negative Breast Cancers (TNBC)
    Tanei, T.
    Rodriguez, A. A.
    Dobrolecki, L.
    Choi, D. S.
    Landis, M.
    Chang, J. C.
    CANCER RESEARCH, 2012, 72
  • [3] Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer
    Chougule, Mahavir B.
    Patel, Apurva R.
    Jackson, Tanise
    Singh, Mandip
    PLOS ONE, 2011, 6 (03):
  • [4] Ixabepilone Alone or With Cetuximab as First-Line Treatment for Advanced/Metastatic Triple-Negative Breast Cancer
    Tredan, Olivier
    Campone, Mario
    Jassem, Jacek
    Vyzula, Rostislav
    Coudert, Bruno
    Pacilio, Carmen
    Prausova, Jana
    Hardy-Bessard, Anne-Claire
    Arance, Ana
    Mukhopadhyay, Pralay
    Aloe, Alessandra
    Roche, Henri
    CLINICAL BREAST CANCER, 2015, 15 (01) : 8 - 15
  • [5] Antitumor activity of celecoxib with docetaxel on human triple-negative breast cancer cells
    Ajikanari, Oktay
    Miaadi, Elham
    Hedayat, Mohaddeseh
    Jafari, Reza
    Asghari, Rahim
    Zolbanin, Naime Majidi
    GENE REPORTS, 2025, 38
  • [6] Combination of docetaxel with sulforaphane synergistically inhibits triple negative breast cancer and cancer stem cells
    Burnett, Joseph P.
    Shah, Ronack B.
    Paholak, Hayley J.
    McDermott, Sean P.
    Tsume, Yasuhiro
    Wicha, Max W.
    Sun, Duxin
    CANCER RESEARCH, 2015, 75
  • [7] Breast cancer stem cells in triple negative vs. non triple negative breast cancer
    Comanescu, M. V.
    Dobre, M.
    Ardeleanu, C.
    Butur, G.
    Bussolati, G.
    HISTOPATHOLOGY, 2012, 61 : 17 - 17
  • [8] Regulation of cancer stem cells in triple negative breast cancer
    Fultang, Norman
    Chakraborty, Madhuparna
    Peethambaran, Bela
    CANCER DRUG RESISTANCE, 2021, 4 (02) : 321 - 342
  • [9] Proliferation of cancer stem cells in triple negative breast cancer
    Sazonov, S.
    Brilliant, A.
    Brilliant, Y.
    BREAST, 2017, 32 : S29 - S30
  • [10] Antitumor activity of capecitabine in combination with bevacizumab and cyclophosphamide in triple-negative breast cancer xenograft model
    Yanagisawa, Mieko
    Yorozu, Keigo
    Satoh, Fumi
    Kurasawa, Mitsue
    Yamamoto, Kaname
    Fujimoto-Ouchi, Kaori
    CANCER RESEARCH, 2011, 71
12345